BIIB Biogen Inc

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

$275.58  +1.54 (0.56%)
As of 05/10/2021 15:59:53 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/08/2001
Outstanding shares:  150,554,750
Average volume:  947,382
Market cap:   $40,967,453,023
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09062X103
ISIN:        US09062X1037
Sedol:      2455965
Valuation   (See tab for details)
PE ratio:   13.70
PB ratio:   3.86
PS ratio:   3.25
Return on equity:   28.19%
Net income %:   23.89%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy